jjzz国产-正在播放国产91-福利视频在线-台湾妹中文娱乐网-半推半就一ⅹ99av-每日更新av-色综合99久久久无码国产精品-www在线观看视频-亚洲女人18毛片水真多-求欧美精品网址-国产一区二区91-综合网天天-我的丝袜美腿尤物麻麻-欲奴性猛交3未删减-在线看一区二区-亚州一级-国产成人在线一区-顶臀精品视频www-欧美在线一区二区三区四区-精品二区视频-粉嫩av渣男av蜜乳av-国产香蕉一区-www.五月天com-中国女人69xxxx-欧美国产视频在线观看-久久亚洲伦理-久久精品一本

歡迎進(jìn)入上海起發(fā)實(shí)驗(yàn)試劑有限公司!
新聞中心
首頁(yè) > 新聞中心 > 熱烈祝賀起發(fā)實(shí)驗(yàn)試劑有限公司成為NeoClone中國(guó)代理

熱烈祝賀起發(fā)實(shí)驗(yàn)試劑有限公司成為NeoClone中國(guó)代理

 更新時(shí)間:2012-11-21 點(diǎn)擊量:2485

 熱烈祝賀起發(fā)實(shí)驗(yàn)試劑有限公司成為NeoClone中國(guó)代理!

 

Our Collaborators

NeoClone has focused its business on growing through collaboration.  As we continue to refine our approach to developing fully human antibodies we have partnered with other groups to help validate our system.  Our current collaborators include:

  • University of Wisconsin - Madison, Dr. Manish Patankar, PhD. Dr. Patankar is a noted expert in the area of ovarian cancer and NeoClone is working with him to develop fully human antibodies for the treatment of this devastating disease.
  • University of California - Los Angeles, Dr. Kathie Ferbas, PhD. Dr. Ferbas has an active program for discovering new treatments for AIDS and is working with NeoClone to advance these research goals.
  • InflammatoRx Inc., is an early stage company located in Quebec, Canada. NeoClone is working with InflammatoRx to develop fully human antibodies against their inflammatory biomarker of interest.

NeoClone does have capacity for additional collaboration. Please contact us if this is of interest to you.